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Ms. Worcestor of the Tallahassee Bureau reported in Octo-
ber 2003 that Dr. Joseph Bruner told a world conference
in Lisbon that intrauterine myelomeningocele repair
(IUMR) results in fewer urinary tract infections, less gas-
trointestinal reflux, improved leg function and cognitive
development and less need for a cerebrospinal fluid
shunt. Our experience has been with only 22 cases. The
authors of articles from Children's Hospital of Philadel-
phia (CHOP) and Vanderbilt admit to premature births
causing death (5 or 0.03%), infection, development of
demoid tumours causing paralysis and maternal morbid-
ity (N Engl J Med 2002). And their latest scientific article
stated their CSF shunt rate is only 54.8 % (Pediat Neuro-
surg 2003). Our data are from five centres with experience
in following patients referred for IUMR to CHOP, Vander-
bilt or San Francisco. 20 of 22 mother/patients pairs
(91%) are known to have significant complications as fol-
lows: 18/22 (82%) have CSF shunts one of whom had car-
diac arrest due to high CSF pressure (2 were lost to follow
up because their local centre recommended a shunt but
the IUMR centre did not), 4 (17%) had the IUMR site
dehisce, 4 (17%) developed sepsis – 3 meningitis and 1
sepsis and intracranial bleed due to prematurity, 7 had
symptoms of Chiari II (30%) of which 3 (14%) were
decompressed and 1 has required both gastrostomy and
tracheotomy with ventilation, 8 patients (36%) were born
prematurely and spent prolonged time in the neonatal
intensive care nursery, 2 patients had hydromyelia, and
one patient each developed mental retardation, tethered
cord, broken femur, scoliosis or kyphosis as young
infants. Five mothers developed significant complications
as follows: one each rupture of the uterus, abruption of
the placenta, intrauterine haemorrhage, dehiscence of her
abdominal wound and oligohydramnios. These percent-
ages add up to greater than the 91% because some indi-
vidual pairs had more than one complication.
Conclusion
The Management of Myelomeningocele Study (MOMS)
being funded by the U S Government in the 3 centres
mentioned above is critically important
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